Abstract
Tumor lysis syndrome (TLS) is characterized by hyperkalemia, hyperuricemia, hypocalcemia and hyperphosphatemia. This report describes a case of hypercalcemia in TLS in a patient with diffuse large B cell lymphoma.
This is a preview of subscription content, log in via an institution to check access.
References
Howard SC, Jones DP, Pui CH (2011) The tumor lysis syndrome. N Engl J Med 364(19):1844–1854
Doane L (2002) Overview of tumor lysis syndrome. Semin Oncol Nurs 18(3 Suppl):2–5
Howard SC, Ribeiro RC, Pui C-H (2006) Acute complications. In: Pui C-H (ed) Childhood leukemias. Cambridge University Press, Cambridge, pp 709–749
Burt ME, Brennan MF (1980) Incidence of hypercalcemia and malignant neoplasm. Arch Surg 115:705
Hewison M, Kantorovich V, Liker HR, Van Herle AJ, Cohan P, Zehnder D, Adams JS (2003) Vitamin D mediated hypercalcemia in lymphoma: evidence for hormone production by tumor-adjacent macrophages. J Bone Miner Res 18:579–582
Author information
Authors and Affiliations
Corresponding author
Additional information
This paper was presented at Lymphoma & Myeloma 2012, An International Congress on Hematologic Malignancies, New York, NY.
Rights and permissions
About this article
Cite this article
Shah, B.K. Hypercalcemia in Tumor Lysis Syndrome. Indian J Hematol Blood Transfus 30 (Suppl 1), 88–89 (2014). https://doi.org/10.1007/s12288-013-0264-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12288-013-0264-1